COG Insider Trading

Insider Ownership Percentage: 31.98%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Cambridge Cognition Insider Trading History Chart

This chart shows the insider buying and selling history at Cambridge Cognition by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cambridge Cognition Share Price & Price History

Current Price: GBX 44
Price Change: Price Decrease of -0.4 (-0.90%)
As of 07/22/2024 07:21 AM ET

This chart shows the closing price history over time for COG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cambridge Cognition Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2023Debra LeevesInsiderBuy10,000GBX 112£11,200
7/21/2022Matthew StorkInsiderBuy22,950GBX 113£25,933.50
See Full Table

SEC Filings (Institutional Ownership Changes) for Cambridge Cognition (LON:COG)

36.65% of Cambridge Cognition stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cambridge Cognition logo
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Read More on Cambridge Cognition

Today's Range

Now: GBX 44
Low: 43.55
High: 45

50 Day Range

MA: GBX 42.13
Low: 38
High: 47.75

52 Week Range

Now: GBX 44
Low: 37
High: 99.60

Volume

6,160 shs

Average Volume

59,325 shs

Market Capitalization

£15.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Cambridge Cognition?

Cambridge Cognition's top insider shareholders include:
  1. Debra Leeves (Insider)
Learn More about top insider investors at Cambridge Cognition.